Johns Hopkins

This is your central portal for breaking news, the latest research and important updates from Johns Hopkins. Bookmark this page and check back often for updates.

Cover Story

Therapeutic Drug Monitoring Not Ready for Prime Time in Rheumatology

Healio Rheumatology, January 2020
Common sense might dictate that, in maintaining health and wellness, being proactive is generally better than being reactive. But the practice of…
Meeting NewsPerspective

Twice-yearly inclisiran reduces LDL in ASCVD, FH

Cardiology Today, January 2020
Inclisiran, an investigational cholesterol-lowering therapy, reduced LDL in high-risk patients with atherosclerotic CVD and in those with…

Differences in dyslipidemia guidelines underscore complexity of CVD prevention

Cardiology Today, January 2020
Ethan Tumarkin, MD, PhD; Marc Engels, MD, PhD; Seth S. Martin, MD, MHS; Rhanderson Cardoso, MD
The use of lipid-lowering therapy has been a hallmark of CV risk reduction for several decades. The cornerstone of CV prevention is risk assessment…

ASH presents Scholar Awards to fellows, junior faculty

December 22, 2019
ASH announced the recipients of its 2019 Scholar Awards. The awards — presented to hematologists in the United States and Canada who conduct…

Should physicians prescribe antivirals to patients at high risk for flu-related complications more than 2 days after symptom onset?

Infectious Diseases in Children, December 2019
The release of the latest iteration of the Infectious Diseases Society of America guidelines on the management of influenza are a welcome addition…
Cover Story

Therapeutic Drug Monitoring: Empirical Evidence Catches up to Common Sense

Healio Gastroenterology, December 2019
Common sense might dictate that, in maintaining health and wellness, being proactive is generally better than being reactive. But the practice of…
FDA News

FDA advisory committee unanimously supports approval of tazemetostat for epithelioid sarcoma

December 18, 2019
The FDA’s Oncologic Drugs Advisory Committee, or ODAC, today voted 11-0 in favor of approval of tazemetostat for the treatment of adults with…
Meeting NewsPerspective

Azacitidine plus pembrolizumab safe, feasible for certain patients with AML

December 18, 2019
ORLANDO — Azacitidine in combination with pembrolizumab appeared to be a safe and feasible regimen for patients with relapsed or refractory…
Meeting NewsPerspective

Sutimlimab demonstrates ‘rapid, sustained’ responses in cold agglutinin disease

December 10, 2019
ORLANDO — Sutimlimab, a first-in-class selective inhibitor of the complement pathway, induced rapid improvement in hemoglobin levels and…
Meeting News

Complement inhibition may be effective therapeutic strategy for antiphospholipid syndrome

December 9, 2019
ORLANDO — Patients with catastrophic antiphospholipid syndrome appeared to have high rates of mutations in complement regulatory genes that…

Partnership funds research to assess connection between cancer, aging

December 2, 2019
The Partnership for Aging and Cancer Research Program awarded seven grants intended to fund research into the link between aging and cancer. The…

Hematologists, oncologists elected to National Academy of Medicine

October 30, 2019
The National Academy of Medicine announced the election of 90 regular members and 10 international members. Election to the academy —…

Monday Night IBD offers GIs, experts a new way to discuss cases

October 21, 2019
The phrase “Monday night” often instills images of professional football played under the lights in front of national audiences. However…

Molecular test shows potential for faster breast cancer diagnosis

October 10, 2019
A novel molecular test developed by researchers at Johns Hopkins Kimmel Cancer Center demonstrated the ability to quickly and accurately distinguish…

The Leukemia & Lymphoma Society awards $13.8 million for research into pediatric blood cancers

October 9, 2019
The Leukemia & Lymphoma Society awarded $13.8 million in new pediatric research grants designed to identify more effective and precise treatments…

Researchers share Nobel Prize for discoveries that may improve treatment of cancer, anemia

October 7, 2019
Three scientists — two from the United States and one from England — the Nobel Prize in Medicine or Physiology for their discoveries of…
In the Journals

Circulating tumor DNA detection linked to high risk for breast cancer relapse

October 3, 2019
Circulating tumor DNA detection during follow-up for early-stage breast cancer appeared associated with high risk for future relapse, according to…
Cover Story

Growing incidence of Merkel cell carcinoma draws researchers’ attention

HemOnc Today, September 25, 2019
A dramatic increase in the rate of Merkel cell carcinoma has attracted new attention to this rare and aggressive skin cancer. Incidence of the…
Meeting NewsPerspective

High-dose radiation effective in oligometastatic prostate cancer

September 18, 2019
Stereotactic ablative radiation appeared to be an effective and safe treatment for men with oligometastatic prostate cancer, with significant…

CAR T-cell therapy has some patients crowdfunding to cover costs

September 13, 2019
Aletta Weiss plans to undergo chimeric antigen receptor T-cell treatment for relapsed large B-cell lymphoma, and she’s turning to GoFundMe for…